S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
NASDAQ:SBTX

Silverback Therapeutics News Headlines

$48.06
-1.54 (-3.10 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$47.22
Now: $48.06
$51.41
50-Day Range
$41.00
MA: $45.90
$51.76
52-Week Range
$24.22
Now: $48.06
$54.41
Volume141,335 shs
Average Volume187,825 shs
Market Capitalization$1.59 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Silverback Therapeutics (NASDAQ SBTX) News Headlines Today

Source:
SourceHeadline
Silverback Therapeutics (NASDAQ:SBTX) Trading Up 7.1%Silverback Therapeutics (NASDAQ:SBTX) Trading Up 7.1%
americanbankingnews.com - February 16 at 9:14 PM
Silverback Therapeutics to Present at Upcoming Investor ConferencesSilverback Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - February 16 at 11:12 AM
Silverback Therapeutics, Inc. (NASDAQ:SBTX) Sees Significant Increase in Short InterestSilverback Therapeutics, Inc. (NASDAQ:SBTX) Sees Significant Increase in Short Interest
americanbankingnews.com - February 15 at 9:06 AM
Silverback Therapeutics (NASDAQ:SBTX) Trading Down 7.5%Silverback Therapeutics (NASDAQ:SBTX) Trading Down 7.5%
americanbankingnews.com - February 5 at 2:10 AM
Silverback Therapeutics Inc.Silverback Therapeutics Inc.
barrons.com - January 1 at 11:34 PM
Silverback Therapeutics IncSilverback Therapeutics Inc
reuters.com - December 13 at 12:42 AM
Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesSilverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
benzinga.com - December 10 at 10:26 PM
Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesSilverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 10 at 8:28 AM
This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.